Plasma brain natriuretic peptide concentration: impact of age and gender.
about
Cardiopulmonary laboratory biomarkers in the evaluation of acute dyspneaClinical Applications of Natriuretic Peptides in Assessment of Valvular Heart DiseaseThe role of natriuretic peptides for the diagnosis of left ventricular dysfunctionEffects of biological sex on the pathophysiology of the heartBiomarkers of acute myocardial infarction in the elderly: troponin and beyondWhy are sex and gender important to basic physiology and translational and individualized medicine?Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failureBiomarkers in heart failure: the importance of inconvenient detailsCoagulation, inflammation and myocardial dysfunction in unstable coronary artery disease and the influence of glycoprotein IIb/IIIa inhibition and low molecular weight heparinPrevalence of heart failure and atrial fibrillation in minority ethnic subjects: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)Role of circulating factors in cardiac aging.Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure.Impaired natriuretic and renal endocrine response to acute volume expansion in pre-clinical systolic and diastolic dysfunction.Relationship between B-type natriuretic peptide levels and echocardiographic indices of left ventricular filling pressures in post-cardiac surgery patients.Age-related pulmonary crackles (rales) in asymptomatic cardiovascular patients.B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study.Value of N-terminal pro brain natriuretic peptide in the elderly: data from the prospective Copenhagen Hospital Heart Failure study (CHHF).Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study.N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agentHuman hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP.Diagnostic accuracy of plasma NT-proBNP levels for excluding cardiac abnormalities in the very elderly.Plasma brain natriuretic peptide levels are elevated in patients with cancer.Biomarkers and cardiovascular risk assessment for primary prevention: an update.Secretion of prohormone of B-type natriuretic peptide, proBNP1-108, is increased in heart failure.Association of cardiac and renal function with extreme N-terminal fragment pro-B-type natriuretic peptide levels in elderly patients.BNP molecular forms and processing by the cardiac serine protease corin.The plasma B-type natriuretic peptide levels are low in males with stable ischemic heart disease (IHD) compared to those observed in patients with non-IHD: a retrospective studyN-Terminal Pro-B-type Natriuretic Peptide Levels in the Korean General PopulationThe effect of the brain-type natriuretic peptide single-nucleotide polymorphism rs198389 on test characteristics of common assaysMeta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction.Association between resting heart rate and N-terminal pro-brain natriuretic peptide in a community-based population study in Beijing.Sex- and gender-specific research priorities for the emergency management of heart failure and acute arrhythmia: proceedings from the 2014 Academic Emergency Medicine Consensus Conference Cardiovascular Research Workgroup.B-type natriuretic peptides improve cardiovascular disease risk prediction in a cohort of womenUse of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease.Natriuretic peptides in the diagnosis and management of heart failureN-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients.Effects of oral contraceptives on natriuretic peptide levels in women with hypothalamic amenorrhea: a pilot study.The increasing impact of laboratory medicine on clinical cardiology.Influence of sex and hormone status on circulating natriuretic peptides.
P2860
Q26745756-656449BA-E3EF-4FF3-8C67-78F7EEE5EE40Q26799058-7E869D42-4ACD-4B12-9CE9-46B3B5270DA6Q26825665-3BDE78ED-6522-4132-9021-09456DB2DA6DQ26866520-D07649BB-1D2D-4548-BD2E-86B5394B5E09Q27005967-D427CD69-D143-48B6-9B52-153239D0EE74Q27022386-A446A7F0-DA27-4763-AAB6-152AE3BE945EQ27027081-79A7273E-90F9-467D-88D7-642A841D4BD4Q28067646-678FDF21-01B9-45AE-AD36-C66AA6D5F0CEQ28208874-CD2ADDB3-9B9E-4A0E-A05E-2A7F80E55C81Q28742689-1A7E857C-F9A6-49D7-A84C-471E378EC54FQ30234641-E09752EB-B448-4FBA-84D8-C4222560DD60Q30359729-0AE88336-364F-4A81-8025-4492F390851CQ30446941-54319ED0-4E02-4A48-A88F-901EC37503BBQ30485218-DFAC43C8-759C-481C-9AE1-4564A5F34337Q30492837-B598146F-61BA-4BAB-BAEB-B7A2C6A8C3C2Q30885744-01907AF1-4CED-4973-BE8B-5A389050A709Q30908639-EA5190A2-7DC8-4CA2-8541-0F53703301BCQ30919400-1ABCD4D1-A89B-41EC-A748-5A7727BFD775Q33506869-4EE3C83E-8115-45F0-BE33-E7AA24FA100FQ33573360-3489F59B-E834-409C-A183-E6544843C4CBQ33698918-03567EAB-51CE-4709-ABB3-BC64C0CB1AB2Q33744529-FB787B64-EEB7-428D-B81F-DECD8B82FFB5Q33751866-7B41BC9E-02C1-41ED-843D-A329CA1F9D9DQ33927398-5334EA83-84DE-4BE7-BF9A-9118A13F1BFEQ33994980-2FFC8B7B-5A36-4E5F-9D7B-760B11431DDEQ34352658-99BDBEFD-CB69-4408-8C68-0DE7D5AA9577Q34369603-5FA46CBD-DCE1-48F8-B70F-86A7304F2FEBQ34433995-BC85B103-7E73-4422-A286-8F919D085F9FQ34512556-BA10D0A6-0EE9-4039-91A7-129D25F3A692Q34616035-041DBB20-0E91-4952-A3D2-809866D8A4E3Q34753074-7C7B40F2-B8D4-4F04-B17A-73FE0BFF0E8CQ34787204-F93E29C2-4225-4A41-9C3F-EC5B1DA8A451Q34836591-B198804C-6C2A-4863-9DB1-798608A53161Q34954819-8E98D23D-28CC-475D-9757-A77FF78F29DEQ34970160-66D14E2D-3E5A-475D-A56D-D3D1D1006F0FQ35015563-CE38A6BC-DF4E-4807-86E1-7F6A9B48D8D0Q35040620-C264AA76-DB2B-4A63-8BDC-BA253549ABFCQ35114062-14A37182-6D20-4179-9A6B-44ECA42CBF82Q35206514-E85508F8-FBD0-4F0E-8160-BB48C6F2E32DQ35207706-3EF9EF8F-7AFE-440C-99DD-C90689A38D6C
P2860
Plasma brain natriuretic peptide concentration: impact of age and gender.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Plasma brain natriuretic peptide concentration: impact of age and gender.
@ast
Plasma brain natriuretic peptide concentration: impact of age and gender.
@en
Plasma brain natriuretic peptide concentration: impact of age and gender.
@nl
type
label
Plasma brain natriuretic peptide concentration: impact of age and gender.
@ast
Plasma brain natriuretic peptide concentration: impact of age and gender.
@en
Plasma brain natriuretic peptide concentration: impact of age and gender.
@nl
prefLabel
Plasma brain natriuretic peptide concentration: impact of age and gender.
@ast
Plasma brain natriuretic peptide concentration: impact of age and gender.
@en
Plasma brain natriuretic peptide concentration: impact of age and gender.
@nl
P2093
P1476
Plasma brain natriuretic peptide concentration: impact of age and gender.
@en
P2093
Douglas W Mahoney
John C Burnett
Kent R Bailey
Margaret M Redfield
Richard J Rodeheffer
P304
P356
10.1016/S0735-1097(02)02059-4
P407
P577
2002-09-01T00:00:00Z